The DOI matches its Crossref record; 53 of the 59 references it cites were found in a registry or an index.
Persistent STAT3 Activation in Colon Cancer Is Associated with Enhanced Cell Proliferation and Tumor Growth
Open accessAbstract
Colorectal carcinoma (CRC) is a major cause of morbidity and mortality in Western countries. It has so far been molecularly defined mainly by alterations of the Wnt pathway. We show here for the first time that aberrant activities of the signal transducer and activator of transcription STAT3 actively contribute to this malignancy and, thus, are a potential therapeutic target for CRC. Constitutive STAT3 activity was found to be abundant in dedifferentiated cancer cells and infiltrating lymphocytes of CRC samples, but not in non-neoplastic colon epithelium. Cell lines derived from malignant colorectal tumors lost persistent STAT3 activity in culture. However, implantation of colon carcinoma cells into nude mice resulted in restoration of STAT3 activity, suggesting a role of an extracellular stimulus within the tumor microenvironment as a trigger for STAT activation. STAT3 activity in CRC cells triggered through interleukin-6 or through a constitutively active STAT3 mutant promoted cancer cell multiplication, whereas STAT3 inhibition through a dominant-negative variant impaired IL-6-driven proliferation. Blockade of STAT3 activation in CRC-derived xenograft tumors slowed down their development, arguing for a contribution of STAT3 to colorectal tumor growth.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“IL-6 via STAT-3 has been shown to promote tumor cell proliferation in many cancers, including oral squamous cell carcinoma via DNA hypomethylation (31), prostate cancer through androgen receptor activation (32), and colon cancer (33).”
From Tumor-Induced Inflammatory Cytokines and the Emerging Diagnostic Devices for Cancer Detection and Prognosis (2021) · cites this paper as [33]
In the citing paper
“Constitutive STAT3 signaling has been implicated in aberrant cell growth and proliferation in many cancers, including head and neck squamous cell carcinoma, colorectal carcinoma, melanoma, glioblastoma multiforme, multiple myeloma, non-small cell lung cancer, and others.58,69–73”
From Critical analysis of the potential for targeting STAT3 in human malignancy (2013) · cites this paper as [69]
Citations
Cites
Bromberg, J. F., Wrzeszczynska, M. H., Devgan, G., Zhao, Y., Pestell, R. G., Albanese, C., & Darnell, J. E. (1999) · Cell · doi:10.1016/s0092-8674(00)81959-5 · Cited by 2,790
Bowman, T., Garcia, R., Turkson, J., & Jove, R. (2000) · Oncogene · doi:10.1038/sj.onc.1203527 · Cited by 1,743
Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality
Takeda, K., Noguchi, K., Shi, W., Tanaka, T., Matsumoto, M., Yoshida, N., Kishimoto, T., & Akira, S. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.8.3801 · Cited by 1,323
O’Shea, J. J., Gadina, M., & Schreiber, R. D. (2002) · Cell · doi:10.1016/s0092-8674(02)00701-8 · Cited by 1,137
Akira, S., Nishio, Y., Inoue, M., Wang, X.-J., We, S., Matsusaka, T., Yoshida, K., Sudo, T., Naruto, M., & Kishimoto, T. (1994) · Cell · doi:10.1016/0092-8674(94)90235-6 · Cited by 1,019
Ory, D., Neugeboren, B. I., & Mulligan, R. C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11400 · Cited by 926
Bromberg, J. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15617 · Cited by 863
Levy, D. E., & Lee, C. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15650 · Cited by 834
Garcia, R., Bowman, T. L., Niu, G., Yu, H., Minton, S., Muro‐Cacho, C., Cox, C. E., Falcone, R., Fairclough, R., Parsons, S. J., et al. (2001) · Oncogene · doi:10.1038/sj.onc.1204349 · Cited by 756
Levy, D. E., & Lee, C.-K. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215650 · Cited by 734
Flagged first, then by citations
6 of the 59 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 201–300 of 433
The stem-like STAT3-responsive cells of zebrafish intestine are WNT/β-catenin dependent
Peron, M., Dinarello, A., Meneghetti, G., Martorano, L., Facchinello, N., Vettori, A., Licciardello, G., Tiso, N., & Argenton, F. (2020) · Development · doi:10.1242/dev.188987 · Cited by 31
Key biomarkers within the colorectal cancer related inflammatory microenvironment
Calu, V., Ionescu, A., Stanca, L., Geicu, O. I., Iordache, F., Pisoschi, A. M., Șerban, A. I., & Bîlteanu, L. (2021) · Scientific Reports · doi:10.1038/s41598-021-86941-5 · Cited by 31
Lee, S. H., Cho, Y.-C., & Lim, J. S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22042075 · Cited by 31
Shah, M. A., Yoshino, T., Tebbutt, N. C., Grothey, A. F., Tabernero, J. M., Xu, R., Cervantes, A. M. R., Oh, S. C., Yamaguchi, K., Fakih, M., et al. (2022) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2022.11.002 · Cited by 31
Darvin, P., Joung, Y. H., Sp, N., Kang, D. Y., Byun, H. J., Hwang, D., Cho, K. H., Park, K. D., Lee, H., & Yang, Y. M. (2015) · Journal of Functional Foods · doi:10.1016/j.jff.2015.03.020 · Cited by 32
Yamamoto, T., Tsunedomi, R., Nakajima, M., Suzuki, N., Yoshida, S., Tomochika, S., Xu, M. Q., Nakagami, Y., Matsui, H., Tokumitsu, Y., et al. (2023) · Annals of Surgical Oncology · doi:10.1245/s10434-023-13527-y · Cited by 30
Topological patterns in microRNA–gene regulatory network: studies in colorectal and breast cancer
Sengupta, D., & Bandyopadhyay, S. (2013) · Molecular BioSystems · doi:10.1039/c3mb25518b · Cited by 29
The Insulin-like Growth Factor System and Colorectal Cancer
Gligorijević, N., Dobrijević, Z., Šunderić, M., Robajac, D., Četić, D., Penezić, A., Miljuš, G., & Nedić, O. (2022) · Life · doi:10.3390/life12081274 · Cited by 30
Albasanz‐Puig, A., Murray, J., Namekata, M., & Wijelath, E. S. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.10.037 · Cited by 29
ATF3 Activates Stat3 Phosphorylation through Inhibition of p53 Expression in Skin Cancer Cells
Hao, Z.-F., Ao, J., Zhang, J., Su, Y.-M., & Yang, R. (2013) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2013.14.12.7439 · Cited by 30
Catestatin Regulates Epithelial Cell Dynamics to Improve Intestinal Inflammation
Eissa, N., Hussein, H. H., Mesgna, R., Bonin, S., Hendy, G. N., Metz‐Boutigue, M., Bernstein, C. N., & Ghia, J. (2018) · Vaccines · doi:10.3390/vaccines6040067 · Cited by 29
Xu, X., Wu, X., Jiang, Q., Sun, Y., LIU, H., CHEN, R., & Wu, S. (2015) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2015.2364 · Cited by 28
Rademaker, G., Costanza, B., Bellier, J., Herfs, M. F., Peiffer, R., Agirman, F., Maloujahmoum, N., Habraken, Y., Delvenne, P., Bellahcène, A., et al. (2019) · Oncogenesis · doi:10.1038/s41389-019-0130-6 · Cited by 29
Obesity and Inflammation: Colorectal Cancer Engines
Malhab, L. J. B., & Abdel‐Rahman, W. M. (2021) · Current Molecular Pharmacology · doi:10.2174/1874467214666210906122054 · Cited by 28
Emerging Therapeutic Agents for Colorectal Cancer
Nalli, M., Puxeddu, M., Regina, G. L., Gianni, S., & Silvestri, R. (2021) · Molecules · doi:10.3390/molecules26247463 · Cited by 29
Activation of the JAK-STAT3 pathway is associated with the growth of colorectal carcinoma cells
WEI, X., Wang, G., LI, W., Hu, X., HUANG, Q., Xu, K., Lou, W., Jia Rui, W. U., Chen, L., LOU, Q., et al. (2013) · Oncology Reports · doi:10.3892/or.2013.2858 · Cited by 28
Zhao, R., Hu, Z., Zhang, X., Huang, S., Yu, G., Wu, Z. B., Yu, W., Lu, J., & Ruan, B. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-023-01421-9 · Cited by 31
Liu, X., Zhang, H., Fan, Y., Cai, D., Lei, R., Wang, Q., Li, Y., Shen, L., Gu, Y., Zhang, Q., et al. (2024) · Advanced Science · doi:10.1002/advs.202405332 · Cited by 27
Genome-Wide Uncovering of STAT3-Mediated miRNA Expression Profiles in Colorectal Cancer Cell Lines
Zhang, J., Luo, X., Li, H., Deng, L., & Wang, Y. (2014) · BioMed Research International · doi:10.1155/2014/187105 · Cited by 27
Corticotropin-Releasing Hormone Receptor 2 Signaling Promotes Mucosal Repair Responses after Colitis
Hoffman, J. M., Baritaki, S., Ruiz, J. J., Sideri, A., & Pothoulakis, C. (2015) · American Journal Of Pathology · doi:10.1016/j.ajpath.2015.09.013 · Cited by 27
Discovery and Optimization of a Novel Series of Highly Selective JAK1 Kinase Inhibitors
Grimster, N. P., Anderson, E. K., Alimzhanov, M. B., Bebernitz, G. A., Bell, K., Chuaqui, C. E., Deegan, T. L., Ferguson, A. D., Gero, T. W., Harsch, A., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00076 · Cited by 27
Theiss, A. L. (2013) · JAK-STAT · doi:10.4161/jkst.24150 · Cited by 27
Tan, F. H., Putoczki, T. L., Lou, J., Hinde, E., Hollande, F., Giraud, J., Stylli, S. S., Paradiso, L., Zhu, H., Sieber, O. M., et al. (2018) · Cancers · doi:10.3390/cancers10120526 · Cited by 26
Dhall, A., Patiyal, S., Sharma, N., Naorem, L. D., & Raghava, G. P. S. (2021) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2021.104780 · Cited by 25
Cui, G., Wang, Z., Liu, H., & Pang, Z. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1057181 · Cited by 25
Al-Qasem, A. J., Al‐Howail, H. A., Al‐Swailem, M., Al‐Mazrou, A., Al‐Otaibi, B., Al‐Jammaz, I., Al‐Khalaf, H. H., & Aboussekhra, A. (2015) · Molecular Carcinogenesis · doi:10.1002/mc.22271 · Cited by 25
Critical analysis of the potential for targeting STAT3 in human malignancy
Grandis, J., & Peyser (2013) · OncoTargets and Therapy · doi:10.2147/ott.s47903 · Cited by 24
RETRACTED: Death-Associated Protein Kinase Controls STAT3 Activity in Intestinal Epithelial Cells
Chakilam, S., Gandesiri, M., Rau, T. T., Agaimy, A., Mahadevan, V., Ivanovska, J., Wirtz, R. M., Schulze‐Luehrmann, J., Benderska, N., Wittkopf, N., et al. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.11.026 · Cited by 24
Retracted15-Deoxy-△12,14-Prostaglandin J2 Promotes Resolution of Experimentally Induced Colitis
Kim, W., Jang, J., Zhong, X., Seo, H., & Surh, Y. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.615803 · Cited by 24
Li, W., Lee, M.-R., Kim, T., Kim, Y. W., & Cho, M.-Y. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.02.084 · Cited by 24
Fabiano, A., Calzavara‐Pinton, P., Monari, P., Moggio, E., Pellacani, G., Manganoni, A. M., & Gualdi, G. (2015) · British Journal of Dermatology · doi:10.1111/bjd.13922 · Cited by 23
Oshima, H., Kok, S. Y., Nakayama, M., Murakami, K., Voon, D. C., Kimura, T., & Oshima, M. (2018) · The FASEB Journal · doi:10.1096/fj.201801176r · Cited by 21
Gan, C., Li, Y., Yu, Y., Yu, X., Liu, H., Zhang, Q., Yin, W., Yu, L., & Ye, T. (2019) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2019.115089 · Cited by 23
Beyond chemotherapy: Exploring 5-FU resistance and stemness in colorectal cancer
Singh, U., Kokkanti, R. R., & Patnaik, S. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177294 · Cited by 24
Wu, D., Wang, X., & Zhang, W. (2019) · Cellular and Molecular Biology · doi:10.14715/cmb/2019.65.6.16 · Cited by 22
Yang, W. J., Feng, Q., Li, M., Su, J., Wang, P., Wang, X., Yin, Y., Wang, X., & Zhao, M. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.684262 · Cited by 23
Li, J., Zhu, P., Wang, Y., Jiang, X., Zhang, Z., Zhang, Z., & Yung, K. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154526 · Cited by 22
Lee, Y.-J., Jung, E., Choi, J., Hwang, J.-S., Jeong, E.-J., Roh, Y., Ban, H. S., Kim, S., Kim, S., Kim, S., et al. (2022) · International Journal of Oncology · doi:10.3892/ijo.2022.5461 · Cited by 22
Inflammatory cues acting on the adult intestinal stem cells and the early onset of cancer (Review)
Barbaro, A. D. L., Perletti, G., Bonapace, I. M., & Monti, E. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2490 · Cited by 22
Dai, C., Liu, P., Wang, X., Yin, Y., Jin, W., Shen, L., Chen, Y., Chen, Z., & Wang, Y. (2019) · Journal of Cancer · doi:10.7150/jca.34847 · Cited by 22
Chae, I. G., Kim, D.-H., Kundu, J. K., Jeong, C., Kundu, J. K., & Chun, K. (2014) · Free Radical Research · doi:10.3109/10715762.2014.951838 · Cited by 21
miR-124, a potential therapeutic target in colorectal cancer
Qin, Z., & Liu, X. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s179501 · Cited by 21
Expressional STAT3/STAT5 Ratio is an Independent Prognostic Marker in Colon Carcinoma
Klupp, F., Diers, J., Kahlert, C., Neumann, L., Halama, N., Franz, C., Schmidt, T., Lasitschka, F., Warth, A., Weitz, J., et al. (2015) · Annals of Surgical Oncology · doi:10.1245/s10434-015-4485-4 · Cited by 21
Targeting STAT proteins via computational analysis in colorectal cancer
Dariya, B., Muppala, S., Srivani, G., Momin, S., Alam, A., & Saddala, M. S. (2020) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-020-03893-6 · Cited by 21
Posttranslational modifications as therapeutic targets for intestinal disorders
Choo, J., Heo, G., Pothoulakis, C., & Im, E. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2020.105412 · Cited by 21
Kuang, S., Qi, C., Liu, J., Sun, X., Zhang, Q., Sima, Z., Liu, J., Li, W., & Yu, Q. (2014) · Cancer Science · doi:10.1111/cas.12359 · Cited by 22
Shaw, J., Chen, B., Bourgault, J. P., Jiang, H., Kumar, N., Mishra, J., Valeriote, F. A., Media, J., Bobbitt, K. R., Pietraszkiewicz, H., et al. (2012) · American Journal of Biomedical Sciences · doi:10.5099/aj120100014 · Cited by 21
Stat3 as a molecular target in RNA interference-based treatment of oral squamous cell carcinoma
Nakashiro, K. (1994) · Oncology Reports · doi:10.3892/or_00000085 · Cited by 20
Yu, Y., Kong, R., Cao, H., Yin, Z., Liu, J., Xiang, N., Phan, A. T., Ding, T., Zhao, H., & Wong, S. T. C. (2018) · Oncotarget · doi:10.18632/oncotarget.24563 · Cited by 20
Delgado-Ramirez, Y., Baltazar-Perez, I., Martinez, Y., Callejas, B. E., Medina-Andrade, I., Olguín, J. E., Delgado-Buenrostro, N. L., Chirino, Y. I., Terrazas, L. I., & Leon-Cabrera, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147695 · Cited by 19
Zhao, H., Huang, J., Chen, M., Li, B., Chen, X., & Zhou, M. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.695525 · Cited by 19
Signaling Pathways Involved in 5-FU Drug Resistance in Cancer
Pouya, F. D., Rasmi, Y., & Nemati, M. (2022) · Cancer Investigation · doi:10.1080/07357907.2022.2055050 · Cited by 21
Inflammation suppresses DLG2 expression decreasing inflammasome formation
Keane, S., Herring, M., Rolny, P., Wettergren, Y., & Ejeskär, K. (2022) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-022-04029-7 · Cited by 19
Fan, X., Meng, M., Li, B., Chen, H., Tan, J., Xu, K., Xiao, S., Kwan, H. Y., Liu, Z., & Su, T. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04087-6 · Cited by 19
Luo, K.-W., Ye, W., Li, N., & Cheng, B. (2023) · Journal of Functional Foods · doi:10.1016/j.jff.2023.105977 · Cited by 19
Baniya, M. K., Kim, E. H., & Chun, K. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1418266 · Cited by 19
Basal STAT3 activities are negatively correlated with tumor size in papillary thyroid carcinomas.
Kim, W. G., Choi, H.-J., Kim, W. B., Kim, E., Yim, J. H., Kim, T. Y., Gong, G., Kim, S., Chung, N., & Shong, Y. K. (2012) · PubMed · doi:10.3275/7907 · Cited by 19
Effects of STAT3 silencing on fate of chronic myelogenous leukemia K562 cells
Ma, L., Zhou, M., Shi-hong, W., Ni, C., Jiang, L., Fan, J., & Xia, L. (2010) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2010.483748 · Cited by 19
Cell-Type Specific Metabolic Response of Cancer Cells to Curcumin
Mojzeš, A., Tomljanović, M., Milković, L., Kujundžić, R. N., Gašparović, A. Č., & Gall‐Tros̆elj, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051661 · Cited by 19
RIPK3 Suppresses the Progression of Spontaneous Intestinal Tumorigenesis
Zhao, Q., Guo, J., Cheng, X., Liao, Y., Bi, Y., Gong, Y., Zhang, X., Guo, Y., Wang, X., Yu, W., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.664927 · Cited by 19
El-kott, A. F., ElBealy, E. R., Alshehri, A. S., El-Kenawy, A. E.-M., Khalifa, H. S., & Al‐Ramlawy, A. M. (2021) · Cancer Biomarkers · doi:10.3233/cbm-203257 · Cited by 18
Smad7 Sustains Stat3 Expression and Signaling in Colon Cancer Cells
Maresca, C., Maggio, G. D., Stolfi, C., Laudisi, F., Colella, M., Pacifico, T., Grazia, A. D., Fusco, D. D., Congiu, D., Guida, A. M., et al. (2022) · Cancers · doi:10.3390/cancers14204993 · Cited by 18
Signal transducers and activators of transcription 3 function in lung cancer
Li, Y.-C., Li, C.-J., Zhang, D., & Pan, J. (2013) · Journal of Cancer Research and Therapeutics · doi:10.4103/0973-1482.119100 · Cited by 18
Kim, A., Im, M., & Yeul, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-12934-y · Cited by 17
A novel STAT3 inhibitor, HJC0152, exerts potent antitumor activity in glioblastoma.
Li, Z., Zhu, T., Xu, Y., Wu, C., Chen, J., Ren, Y., Kong, L., Sun, S., Guo, W., Wang, Y., et al. (2019) · PubMed Central · Cited by 18
MLKL inhibits intestinal tumorigenesis by suppressing STAT3 signaling pathway
Zhao, Q., Cheng, X., Guo, J., Bi, Y., Kuang, L., Ren, J., Zhong, J., Pan, L., Zhang, X., Guo, Y., et al. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.56152 · Cited by 18
Dysbiotic microbes and how to find them: a review of microbiome profiling in prostate cancer
Salachan, P. V., & Sørensen, K. D. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02196-y · Cited by 18
Räsänen, K., Lehtinen, E., Nokelainen, K., Kuopio, T., Hautala, L. C., Itkonen, O., Stenman, U., & Koistinen, H. K. (2015) · Molecular Carcinogenesis · doi:10.1002/mc.22447 · Cited by 18
Teng, W.-J., Chen, P., Zhu, F.-Y., Di, K., Zhou, C., Zhuang, J., Cao, X., Yang, J. H., Deng, L.-J., & Sun, C. (2015) · Genetics and Molecular Research · doi:10.4238/2015.may.29.11 · Cited by 18
Ma, L., Liu, X., Roopashree, R., Kazmi, S. W., Jasim, S. A., Vinay, K. P., Fateh, A., Yang, F., Rajabivahid, M., Dehghani-Ghorbi, M., et al. (2025) · Clinical and Experimental Medicine · doi:10.1007/s10238-024-01532-8 · Cited by 17
Wu, Y., Luo, J., & Xu, B. (2023) · Current Research in Toxicology · doi:10.1016/j.crtox.2023.100139 · Cited by 19
Liu, J., Wu, W., Shu-xia, L., Lian-fu, Z., Wang, Y., Yang, J.-Z., & Nan, Y. (2015) · Pathology - Research and Practice · doi:10.1016/j.prp.2015.01.007 · Cited by 16
Li, Z., Shi, X., Li, H., Wang, W., & Li, X. (2019) · Oncology Reports · doi:10.3892/or.2019.7029 · Cited by 15
PHOSPHO-STAT5 Expression is Associated with Poor Prognosis of Human Colonic Adenocarcinoma
Mao, Y., Li, Z.-W., Lou, C., Pang, D., & Zhang, Y. (2011) · Pathology & Oncology Research · doi:10.1007/s12253-010-9321-3 · Cited by 16
Li, M., Wan, G., Yu, H., & Xiong, W. (2019) · FEBS Open Bio · doi:10.1002/2211-5463.12642 · Cited by 16
RetractedLee, H., Choi, Y., Kim, S. H., Zhong, X., Kim, W., Park, J. S., Saeidi, S., Han, B. W., Kim, N., Lee, H. S., et al. (2021) · The FASEB Journal · doi:10.1096/fj.202002392r · Cited by 15
Sastre, D., Baiochi, J. F., Lima, I. M. D. S., de Souza, F. C., Corveloni, A. C., Thomé, C. H., Faça, V. M., Schiavinato, J. L. D. S., Covas, D. T., & Panepucci, R. A. (2019) · BMC Cancer · doi:10.1186/s12885-019-6468-5 · Cited by 15
Shi, X., Shu, L., Qiao, Y., Yao, J., Xie, H., Zhou, L., Wang, H., & Zheng, S. (2021) · Materials Today Nano · doi:10.1016/j.mtnano.2021.100155 · Cited by 15
STAT3 expression correlates with prognosis of thymic epithelial tumors
Li, C., Wang, Z., Liu, Y., Wang, P., & Zhang, R. (2013) · Journal of Cardiothoracic Surgery · doi:10.1186/1749-8090-8-92 · Cited by 15
Yoshida, M., Zhao, L., Grigoryan, G., Shim, H., He, P., & Yun, C. C. (2016) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00419.2015 · Cited by 14
Effect of Soy Isoflavone on Prostate Cancer Cell Apoptosis Through Inhibition of STAT3, ERK, and AKT
Lee, Y., Lee, C., Choi, D., Lee, Y., & Lee, S. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46110743 · Cited by 13
Lee, H. Y., You, D. J., Taylor-Just, A. J., Linder, K. E., Atkins, H., Ralph, L. M., la Cruz, G. D., & Bonner, J. C. (2022) · Inhalation Toxicology · doi:10.1080/08958378.2022.2086651 · Cited by 14
Ke, X., HU, G., Fang, W., Chen, J.-T., Zhang, X., Yang, C., Peng, J., Chen, Y., & Sferra, T. J. (2015) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2015.2083 · Cited by 13
van Caloen, G., Schmitz, S., van Marcke, C., Caignet, X., Mendola, A., Ruys, S. P. D., Roger, P. P., Vertommen, D., & Machiels, J. (2021) · Cancers · doi:10.3390/cancers13061251 · Cited by 13
Keivany, M. R., Asrami, E. S., Besharatloo, M., Latifi, H., & Barjasteh, A. H. (2026) · Cancer Cell International · doi:10.1186/s12935-026-04177-7 · Cited by 14
Marginean, E. C., Gotfrit, J., Marginean, H., Yokom, D. W., Bateman, J., Daneshmand, M., Sud, S., Gown, A. M., Jonker, D. J., Asmis, T. R., et al. (2020) · Translational Oncology · doi:10.1016/j.tranon.2020.100996 · Cited by 12
Joo, M., Heo, J. B., Kim, S., Kim, N., Jeon, H. J., An, Y., Song, G., Kim, J., & Lee, H. J. (2021) · Oncology Reports · doi:10.3892/or.2021.8250 · Cited by 12
Pereira, J., Bessa, C., Matos, P., & Jordan, P. (2022) · Cancers · doi:10.3390/cancers14061393 · Cited by 12
Keystone pathobionts associated with colorectal cancer promote oncogenic reprograming
Jones, J. P., Shi, Q., Nath, R. R., & Brito, I. (2024) · PLoS ONE · doi:10.1371/journal.pone.0297897 · Cited by 12
Zhang, L., Liu, P., Jiang, Y., Fan, D., He, X., Zhang, J., Luo, B., Sui, J., Luo, Y., Fu, X.-Y., et al. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.116448 · Cited by 11
Cioce, M., Fumagalli, M. R., Donzelli, S., Goeman, F., Canu, V., Rutigliano, D., Orlandi, G., Sacconi, A., Pulito, C., Palcau, A. C., et al. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02754-6 · Cited by 11
Li, Q., Ding, Y., Ou, Y., Li, M., Jithavech, P., Buranasudja, V., Sritularak, B., Xu, Y., Rojsitthisak, P., & Han, J. (2023) · Current Pharmaceutical Design · doi:10.2174/0113816128263974231029180947 · Cited by 11
Yang, F., Ye, T., Liu, Z., Fang, A., Luo, Y., Wei, W., Li, Y., Li, Y., Zeng, A., Deng, Y., et al. (2016) · RSC Advances · doi:10.1039/c6ra21533e · Cited by 11
Tegethoff, J. F., Bischoff, R., Saleh, S., Blagojevic, B., Merz, K., & Cheng, X. (2017) · Molecules · doi:10.3390/molecules22091546 · Cited by 11
STAT3 Regulates Proliferation and Immunogenicity of the Ewing Family of TumorsIn Vitro
Behjati, S., Basu, B. P., Wallace, R., Bier, N., Sebire, N. J., Hasan, F., & Anderson, J. (2012) · Sarcoma · doi:10.1155/2012/987239 · Cited by 10
Structural and utational nalysis of ember-pecific STAT unctions
Erdogan, F., Qadree, A., Radu, T. B., Orlova, A., de Araujo, E. D., Israelian, J., Valent, P., Mustjoki, S. M., Herling, M., Moriggl, R., et al. (2021) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2021.130058 · Cited by 10
Self-citationThe role of cytokines in the pathogenesis of malignant neoplasms
Львовна, Р. В., Adamova, G. V., & Oslina, D. S. (2023) · Сибирский научный медицинский журнал · doi:10.18699/ssmj20230202 · Cited by 14
STAT3 and AKT signaling pathways mediate oncogenic role of NRSF in hepatocellular carcinoma
Ma, M., Zhou, Y., Sun, R., Shi, J., Tan, Y., Yang, H., Zhang, M., Shen, R., Xu, L., Wang, Z., et al. (2020) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmaa069 · Cited by 9
Transcriptional regulation of human DUSP4 gene by cancer‐related transcription factors
Varela, T., Conceição, N., Laizé, V., & Cancela, M. L. (2021) · Journal of Cellular Biochemistry · doi:10.1002/jcb.30078 · Cited by 10
Tajima, S., Waki, M., Tsuchiya, T., & Hoshi, S. (2014) · PubMed Central · Cited by 9
Metadata
- Authors
- Corvinus, F. M., Orth, C., Moriggl, R., Tsareva, S. A., Wagner, S., Pfitzner, E. B., Baus, D., Kaufman, R., Huber, L. A., Zatloukal, K., Beug, H., Öhlschläger, P., Schütz, A., Halbhuber, K.-J., & Friedrich, K.
- Affiliations
- Friedrich Schiller University Jena (DE)
- Research Institute of Molecular Pathology (AT)
- Georg Speyer Haus (DE)
- Universität Innsbruck (AT)
- University of Graz (AT)
- Leipzig University (DE)
- Corresponding author
- Friedrich, Karlheinz
- Venue
- Neoplasia
- Publisher
- Elsevier BV
- Published
- 2005-06
- Volume
- 7
- Issue
- 6
- Pages
- 545-555
- ISSN
- 1476-5586 (ISSN-L)
- PMC
- PMC1501283
- OpenAlex
- W2014737409
- Cited by
- 427
- References
- 59
- Citations by year
- 2026: 9 · 2025: 15 · 2024: 27 · 2023: 21 · 2022: 28 · 2021: 40 · 2020: 29 · 2019: 22 · 2018: 15 · 2017: 27 · 2016: 24 · 2015: 30 · 2014: 24 · 2013: 30 · 2012: 17
- FWCI
- 4.53
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Neoplasia (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Publication Server of Goethe University Frankfurt am Main (Goethe University Frankfurt) (submittedVersion, cc-by-nc-nd)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Keywords
- STAT3, colorectal cancer, constitutive STAT3 activation, interleukin-6, cell proliferation, tumor growth, tumor microenvironment, tumor xenografts, dominant-negative STAT3, therapeutic target, infiltrating lymphocytes
- MeSH terms
- Animals, Biopsy, Cell Differentiation, Colonic Neoplasms, DNA, Genes, Dominant, Humans, Immunohistochemistry, Lymphocytes, Mice, Nude, Neoplasm Transplantation, Retroviridae, Time Factors, Blotting, Western, Colorectal Neoplasms, Signal Transduction, Interleukin-6, Cell Line, Tumor, Cell Proliferation, STAT3 Transcription Factor, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review